Quick Takeaways
- Quan Anh Vu has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $217,134.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Quan Anh Vu and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| OCGN | Ocugen, Inc. | Cfo/Cbo | $108,355 | 06 Mar 2023 | ||
| MNPR | Monopar Therapeutics | Chief Financial Officer | $104,925 | +$104,925 | +100% | 26 Dec 2025 |
| FRMM, ETHZ | 180 Life Sciences Corp. | COO / Chief Business Officer | $3,854 | 16 Dec 2021 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|